SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,895.74 315.20
( 0.43%)

Global Indices

Nasdaq

51,839.66 468.68
(0.91%)

Dow Jones

7,763.25 38.12
(0.49%)

Hang Seng

66,308.10 794.11
(1.21%)

Nikkei 225

10,694.57 14.58
(0.14%)

Forex

USD-INR

95.89 0.16
(0.16%)

EUR-INR

109.08 -0.12
(-0.11%)

GBP-INR

126.82 -0.30
(-0.24%)

JPY-INR

0.60 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

CCL Products (India) Ltd

Industry : Tea

BSE Code

ISIN Demat

Book Value()

519600

INE421D01022

103.1301157

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CCL

50.19

13967.02

EPS(TTM)

Face Value()

Div & Yield %

20.84

0.55

Back

genpharmasec limited

Sammaan Capital consolidated net profit declines 27.22% in the June 2026 quarter

Aug 14,2026

Net profit of Sammaan Capital declined 27.22% to Rs 243.30 crore in the quarter ended June 2026 as against Rs 334.30 crore during the previous quarter ended June 2025. Sales declined 31.18% to Rs 1651.93 crore in the quarter ended June 2026 as against Rs 2400.33 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1651.93	2400.33	-31
OPM %	99.91	69.83	-
PBDT	346.12	489.14	-29
PBT	326.01	468.11	-30
NP	243.30	334.30	-27

73,895.74 315.20 ( 0.43%)

51,839.66 468.68 (0.91%)

7,763.25 38.12 (0.49%)

66,308.10 794.11 (1.21%)

10,694.57 14.58 (0.14%)

95.89 0.16 (0.16%)

109.08 -0.12 (-0.11%)

126.82 -0.30 (-0.24%)

0.60 0.00 (-0.20%)